Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing

Nature Communications

Volumn 5, Issue , 2014, Pages

  Wong, Swee Seong ^a   Kim, Kyoung Mee ^b   Ting, Jason C ^a   Yu, Kun ^a,f   Fu, Jake ^c   Liu, Shawn ^d   Cristescu, Razvan ^e   Nebozhyn, Michael ^e   Gong, Lara ^d   Yue, Yong Gang ^a   Wang, Jian ^a   Ronghua, Chen ^e   Loboda, Andrey ^e   Hardwick, James ^e,g   Liu, Xiaoqiao ^e   Dai, Hongyue ^e   Jin, Jason Gang ^c   Ye, Xiang S ^a   Kang, So Young ^b   Do, In Gu ^b   Park, Joon Oh ^b   Sohn, Tae Sung ^b   Reinhard, Christoph ^a   Lee, Jeeyun ^b   Kim, Sung ^b   Aggarwal, Amit ^a   more..

^a ELI LILLY AND COMPANY   (United States)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Shanghai Biocorp ^*  (China)

^d BGI Techsolutions   (Hong Kong)

^e MERCK RESEARCH LABORATORIES   (United States)

^f NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^g PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN;

CANCER; DIGESTIVE SYSTEM DISORDER; DISEASE TREATMENT; GENETIC ANALYSIS; GENOMICS; HETEROGENEITY; HISTOLOGY; MUTATION; PROTEIN; TUMOR;

ADULT; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; CPG ISLAND; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOMIC LANDSCAPE; GERMLINE MUTATION; HUMAN; LANDSCAPE; MALE; MIDDLE AGED; NONSENSE MUTATION; SIGNAL TRANSDUCTION; SOMATIC MUTATION; STOMACH ADENOCARCINOMA; ADENOCARCINOMA; AGED; DNA SEQUENCE; FEMALE; GENETICS; GENOMICS; STOMACH TUMOR; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGED; FEMALE; GENETIC HETEROGENEITY; GENOMICS; HUMANS; MALE; MIDDLE AGED; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 84923312407     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6477     Document Type: Article

References (40)

1. Kang, G. et al. Exome sequencing identifies early gastric carcinoma as an early stage of advanced gastric cancer. PLoS ONE 8, e82770 (2013).
2. Hu, B. et al. Gastric cancer: classification, histology and application of molecular pathology. J. Gastrointest. Oncol. 3, 251-261 (2012).
3. Zang, Z. J. et al. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat. Genet. 44, 570-574 (2012).
4. Wang, K. et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat. Genet. 43, 1219-1223 (2011).
5. Network, T. C. G. A. R. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202-209 (2014).
6. Kakiuchi, M. et al. Recurrent gain-of-function mutations of RHOA in diffusetype gastric carcinoma. Nat. Genet. 46, 583-587 (2014).
7. Lee, Y. S. et al. Genomic profile analysis of diffuse-type gastric cancers. Genome. Biol. 15, R55 (2014).
8. Wang, K. et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat. Genet. 46, 573-582 (2014).
9. Andrechek, E. R. et al. Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential. Proc. Natl Acad. Sci. USA 106, 16387-16392 (2009).
10. Drmanac, R. et al. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 327, 78-81 (2010).
11. Tomasetti, C., Vogelstein, B. & Parmigiani, G. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc. Natl Acad. Sci. 110, 1999-2004 (2013).
12. Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546-1558 (2013).
13. Dulak, A. M. et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat. Genet. 45, 478-486 (2013).
14. Roberts, S. A. et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 45, 970-976 (2013).
15. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214-218 (2013).
16. Youn, A. & Simon, R. Identifying cancer driver genes in tumor genome sequencing studies. Bioinformatics 27, 175-181 (2011).
17. Masica, D. L. & Karchin, R. Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival. Cancer Res. 71, 4550-4561 (2011).
18. Ohue, M. et al. Mutations of the transforming growth factor beta type II receptor gene and microsatellite instability in gastric cancer. Int. J. Cancer. 68, 203-206 (1996).
19. Song, J. H. et al. TGFBR2 frameshift mutation in gastric tumors with microsatellite instability. Mol. Cell Toxicol. 6, 321-326 (2010).
20. Figueiredo, J. et al. The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC. Eur. J. Hum. Genet. 21, 301-309 (2013).
21. Suriano, G. et al. E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells. Hum. Mol. Genet. 12, 3007-3016 (2003).
22. Yamada, H. et al. Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population. Carcinogenesis 28, 2013-2018 (2007).
23. Sulahian, R. et al. An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer. Oncogene. (doi:10.1038/onc.2013517).
24. Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc. Natl Acad. Sci. USA 107, 16910-16915 (2010).
25. Lee, J. et al. High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric adenocarcinoma. PLoS ONE 7, e38892 (2012).
26. Deng, N. et al. A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. Gut 61, 673-684 (2012).
27. Ciriello, G. et al. Emerging landscape of oncogenic signatures across human cancers. Nat. Genet. 45, 1127-1133 (2013).
28. Majewski, I. J. et al. An alpha-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer. J. Pathol. 229, 621-629 (2013).
29. Kaurah, P. et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 297, 2360-2372 (2007).
30. Pasquale, E. B. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat. Rev. Cancer 10, 165-180 (2010).
31. Wang, B. et al. Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell 4, 19-29 (2003).
32. Morissette, G. & Flamand, L. Herpesviruses and chromosomal integration. J. Virol. 84, 12100-12109 (2010).
33. https://www.ncbi.nlm.nih.gov/genomes/GenomesGroup.cgi?taxid=10239&opt= Virus (website accessed on 20th June, 2012).
34. Wu, C. W. et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Genes Chromosomes Cancer 44, 19-28 (2005).
35. Zhao, Y. B., Yang, H. Y., Zhang, X. W. & Chen, G. Y. Mutation in D-loop region of mitochondrial DNA in gastric cancer and its significance. World J. Gastroenterol. 11, 3304-3306 (2005).
36. Ingman, M. & Gyllensten, U. mtDB: Human Mitochondrial Genome Database, a resource for population genetics and medical sciences. Nucleic Acids Res. 34, D749-D751 (2006).
37. Chedotal, A., Kerjan, G. & Moreau-Fauvarque, C. The brain within the tumor: new roles for axon guidance molecules in cancers. Cell Death Differ. 12, 1044-1056 (2005).
38. Biankin, A. V. et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399-405 (2012).
39. Shi, R. et al. Knockdown of Slit2 promotes growth and motility in gastric cancer cells via activation of AKT/beta-catenin. Oncol. Rep. 31, 812-818 (2014).
40. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protocols 4, 44-57 (2008).